Tanshinone IIA Restores Dynamic Balance of Autophagosome/Autolysosome in Doxorubicin-Induced Cardiotoxicity via Targeting Beclin1/LAMP1
暂无分享,去创建一个
Wei Wang | Yong Wang | Chun Li | Weili Li | Qiyan Wang | Mingyan Shao | Dongqing Guo | Xu Chen | Liniger Ma | Xuefeng Zhang | Xiaoping Wang | Qian Zhang | Xuefeng Zhang
[1] K. Cheung,et al. Balancing mTOR Signaling and Autophagy in the Treatment of Parkinson’s Disease , 2019, International journal of molecular sciences.
[2] S. Miyamoto,et al. Autophagy and cardiac aging , 2019, Cell Death & Differentiation.
[3] Chien-Sung Tsai,et al. Tanshinone IIA Inhibits High Glucose-Induced Collagen Synthesis via Nuclear Factor Erythroid 2-Related Factor 2 in Cardiac Fibroblasts , 2018, Cellular Physiology and Biochemistry.
[4] Y. Zhang,et al. Tanshinone IIA protects against cardiac fibrosis through inhibition of β-tubulin expression. , 2018, Journal of biological regulators and homeostatic agents.
[5] Jinhui Wu,et al. Sodium tanshinone IIA sulfonate attenuates cardiac dysfunction and improves survival of rats with cecal ligation and puncture-induced sepsis. , 2018, Chinese journal of natural medicines.
[6] Wenqun Li,et al. Nrf2-dependent antioxidant response mediated the protective effect of tanshinone IIA on doxorubicin-induced cardiotoxicity , 2018, Experimental and therapeutic medicine.
[7] Ke-Ji Chen,et al. Sodium Tanshinone II A Sulfonate for Coronary Heart Disease: A Systematic Review of Randomized Controlled Trials , 2018, Chinese Journal of Integrative Medicine.
[8] Minghui Zhu,et al. Tanshinone IIA protects against subclinical lipopolysaccharide induced cardiac fibrosis in mice through inhibition of NADPH oxidase , 2018, International immunopharmacology.
[9] Jianjian Shi,et al. Disruption of ROCK1 gene restores autophagic flux and mitigates doxorubicin-induced cardiotoxicity , 2018, Oncotarget.
[10] He Huang,et al. Tanshinone IIA ameliorates apoptosis of myocardiocytes by up‐regulation of miR‐133 and suppression of Caspase‐9 , 2017, European journal of pharmacology.
[11] Yuichi Akasaki,et al. The Impact of Autophagy on Cardiovascular Senescence and Diseases. , 2017, International heart journal.
[12] E. Kang,et al. Ezetimibe ameliorates steatohepatitis via AMP activated protein kinase-TFEB-mediated activation of autophagy and NLRP3 inflammasome inhibition , 2017, Autophagy.
[13] A. Ballabio,et al. STUB1 regulates TFEB‐induced autophagy–lysosome pathway , 2017, The EMBO journal.
[14] B. Rodrigues,et al. Autophagy, Metabolic Disease, and Pathogenesis of Heart Dysfunction. , 2017, The Canadian journal of cardiology.
[15] Xuejun Wang,et al. Autophagy modulation: a potential therapeutic approach in cardiac hypertrophy. , 2017, American journal of physiology. Heart and circulatory physiology.
[16] A. Gabizon,et al. Dexrazoxane added to doxorubicin-based adjuvant chemotherapy of breast cancer: a retrospective cohort study with a comparative analysis of toxicity and survival , 2017, Anti-cancer drugs.
[17] P. Trivedi,et al. Autophagic dysregulation in doxorubicin cardiomyopathy. , 2017, Journal of molecular and cellular cardiology.
[18] T. Wróbel,et al. Anti-atherosclerotic effects of pravastatin in brachiocephalic artery in comparison with en face aorta and aortic roots in ApoE/LDLR^−/− mice , 2017, Pharmacological reports : PR.
[19] Ning-fu Wang,et al. MiRNA‐30e mediated cardioprotection of ACE2 in rats with Doxorubicin‐induced heart failure through inhibiting cardiomyocytes autophagy , 2017, Life sciences.
[20] Quanjun Yang,et al. Protective Effects of Dexrazoxane against Doxorubicin-Induced Cardiotoxicity: A Metabolomic Study , 2017, PloS one.
[21] S. Kesler,et al. TFEB ameliorates the impairment of the autophagy-lysosome pathway in neurons induced by doxorubicin , 2016, Aging.
[22] Changzheng Sun,et al. Reduction of atrial fibrillation by Tanshinone IIA in chronic heart failure. , 2016, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[23] Petra C. Kienesberger,et al. Doxorubicin impairs cardiomyocyte viability by suppressing transcription factor EB expression and disrupting autophagy. , 2016, The Biochemical journal.
[24] J. H. Kim,et al. Doxorubicin Regulates Autophagy Signals via Accumulation of Cytosolic Ca2+ in Human Cardiac Progenitor Cells , 2016, International journal of molecular sciences.
[25] M. Chiong,et al. Basal autophagy protects cardiomyocytes from doxorubicin-induced toxicity. , 2016, Toxicology.
[26] J. Ko,et al. PI3K/Akt/mTOR activation by suppression of ELK3 mediates chemosensitivity of MDA-MB-231 cells to doxorubicin by inhibiting autophagy. , 2016, Biochemical and biophysical research communications.
[27] A. Ballabio,et al. TFEB at a glance , 2016, Journal of Cell Science.
[28] M. Isobe,et al. Regulation of autophagy by Beclin 1 in the heart. , 2016, Journal of molecular and cellular cardiology.
[29] P. Nathan,et al. Cardioprotection and Second Malignant Neoplasms Associated With Dexrazoxane in Children Receiving Anthracycline Chemotherapy: A Systematic Review and Meta-Analysis. , 2016, Journal of the National Cancer Institute.
[30] Herman I. May,et al. Doxorubicin Blocks Cardiomyocyte Autophagic Flux by Inhibiting Lysosome Acidification , 2016, Circulation.
[31] J. Edwards,et al. Doxorubicin induced heart failure: Phenotype and molecular mechanisms , 2015, International journal of cardiology. Heart & vasculature.
[32] M. Hamada,et al. Elevated Cardiac Enzymes in Hypertrophic Cardiomyopathy Patients With Heart Failure - A 20-Year Prospective Follow-up Study. , 2016, Circulation journal : official journal of the Japanese Circulation Society.
[33] Paul A Insel,et al. Experimental design and analysis and their reporting: new guidance for publication in BJP , 2015, British journal of pharmacology.
[34] Å. Gustafsson,et al. Therapeutic Targeting of Autophagy: Potential and Concerns in Treating Cardiovascular Disease , 2015, Circulation research.
[35] Jeremy J. Mao,et al. Protein-releasing polymeric scaffolds induce fibrochondrocytic differentiation of endogenous cells for knee meniscus regeneration in sheep , 2014, Science Translational Medicine.
[36] Y. Hua,et al. Sodium tanshinone IIA sulfonate and sodium danshensu open the placental barrier through down-regulation of placental P-glycoprotein in mice: implications in the transplacental digoxin treatment for fetal heart failure. , 2014, International journal of cardiology.
[37] Yong Cheng,et al. Aldehyde dehydrogenase 2 ameliorates doxorubicin-induced myocardial dysfunction through detoxification of 4-HNE and suppression of autophagy. , 2014, Journal of molecular and cellular cardiology.
[38] X. Cen,et al. Ghrelin inhibits doxorubicin cardiotoxicity by inhibiting excessive autophagy through AMPK and p38-MAPK. , 2014, Biochemical pharmacology.
[39] Shidong Kan,et al. Enhancement of Doxorubicin Cytotoxicity by Tanshinone IIA in HepG2 Human Hepatoma Cells , 2014, Planta Medica.
[40] U. Baxa,et al. Mito-Tempol and Dexrazoxane Exhibit Cardioprotective and Chemotherapeutic Effects through Specific Protein Oxidation and Autophagy in a Syngeneic Breast Tumor Preclinical Model , 2013, PloS one.
[41] Sam W. Lee,et al. Identification of ROCK1 kinase as a critical regulator of Beclin1 mediated autophagy during metabolic stress , 2013, Nature Communications.
[42] Andrea Ballabio,et al. Signals from the lysosome: a control centre for cellular clearance and energy metabolism , 2013, Nature Reviews Molecular Cell Biology.
[43] C. Bauvy,et al. Activation of lysosomal function in the course of autophagy via mTORC1 suppression and autophagosome-lysosome fusion , 2013, Cell Research.
[44] Po-Yuan Chen,et al. Tanshinone IIA prevents doxorubicin-induced cardiomyocyte apoptosis through Akt-dependent pathway. , 2012, International journal of cardiology.
[45] Yong Chen,et al. MTORC1 functions as a transcriptional regulator of autophagy by preventing nuclear transport of TFEB , 2012, Autophagy.
[46] A. Ballabio,et al. A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB , 2012, The EMBO journal.
[47] Wan-ying Wu,et al. Proteomic assessment of tanshinone IIA sodium sulfonate on doxorubicin induced nephropathy. , 2011, The American journal of Chinese medicine.
[48] Wan-ying Wu,et al. Tanshinone IIA sodium sulfonate protects against cardiotoxicity induced by doxorubicin in vitro and in vivo. , 2009, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.